// company-profile
ARS Pharmaceuticals, Inc. Insider Trading
SPRYEvery SEC Form 4 insider trading filing for ARS Pharmaceuticals, Inc. (SPRY) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=SPRY" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, ARS Pharmaceuticals, Inc. insiders bought $38K across 12 transactions with no open-market sales.
- Most active insider: Karas Eric with 3 transactions totaling $288K.
- Largest single sale: $250K by Karas Eric on Jun 12, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of ARS Pharmaceuticals, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Casale Donn | SPRY | Award | 898,456 | $0.00 | $0K |
| Jun 24, 2026 | SCHNEIDER PHILLIP M | SPRY | Award | 30,000 | $0.00 | $0K |
| Jun 24, 2026 | Shawver Laura | SPRY | Award | 30,000 | $0.00 | $0K |
| Jun 24, 2026 | Islam Saqib | SPRY | Award | 30,000 | $0.00 | $0K |
| Jun 24, 2026 | RA CAPITAL MANAGEMENT, L.P. | SPRY | Award | 30,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →